JCR Pharmaceuticals Co., Ltd. operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares JCR Pharmaceuticals Co., Ltd. with three other
pharmaceutical manufacturers in Asia:
Dhg Pharmaceutical Joint-Stock Co
sales of 3.78 trillion Dong [US$166.03 million]
of South Korea
(158.60 billion Korean Won [US$141.95 million]
Kyongbo Pharmaceutical Co Ltd
based in South Korea
(186.73 billion Korean Won [US$167.12 million]
JCR Pharmaceuticals Co., Ltd. reported sales of ¥17.44 billion (US$156.60 million)
March of 2016.
increase of 3.5%
versus 2015, when the company's sales were ¥16.86 billion.
This was the fourth straight year of sales growth at JCR Pharmaceuticals Co., Ltd..
Sales of Pharmaceutical Business saw an increase
3.6% in 2016, from
¥16.44 billion to ¥17.04 billion.
Not all segments of JCR Pharmaceuticals Co., Ltd. experienced an increase in sales in 2016:
sales of Medical and Research Equipment Business fell 3.7% to ¥398.35 million.
(However, this segment's sales were only a very small portion of the company's overall sales).